Aligos Therapeutics, Inc. — All Filings
325 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001610717-26-000095 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | — | 0001610717-26-000094 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | — | 0001610717-26-000093 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | — | 0001610717-26-000092 | Mar 11, 2026 | Mar 9, 2026 |
| S-8 | S-8 | 0001193125-26-092647 | Mar 5, 2026 | — |
| 10-K | 10-K | 0001193125-26-092614 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001171843-26-001340 | Mar 5, 2026 | — |
| 3 | — | 0001610717-26-000055 | Feb 19, 2026 | Jan 29, 2026 |
| SCHEDULE 13G/A | — | 0000902664-26-001065 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-001502 | Feb 11, 2026 | — |
| 8-K | 8-K | 0001193125-26-037558 | Feb 4, 2026 | Jan 29, 2026 |
| SCHEDULE 13G/A | — | 0000902664-25-005026 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-268203 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-007075 | Nov 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003590 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-011951 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003496 | Aug 12, 2025 | — |
| S-8 | S-8 | 0001193125-25-174519 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104042 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-005116 | Aug 6, 2025 | — |
| 4 | — | 0001610717-25-000290 | Jul 18, 2025 | Jul 16, 2025 |
| 4 | — | 0001610717-25-000289 | Jul 18, 2025 | Jul 16, 2025 |
| 4 | — | 0001610717-25-000286 | Jul 18, 2025 | Jul 16, 2025 |
| 4 | — | 0001610717-25-000259 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001610717-25-000258 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001610717-25-000257 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001610717-25-000256 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001610717-25-000255 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | — | 0001610717-25-000254 | Jun 26, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0001193125-25-148905 | Jun 26, 2025 | Jun 25, 2025 |
| SCHEDULE 13G | — | 0001172661-25-002361 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000358 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-002357 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-063983 | May 6, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001171843-25-002781 | May 6, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-100542 | Apr 28, 2025 | — |
| ARS | ARS | 0001193125-25-100516 | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001193125-25-100453 | Apr 28, 2025 | Jun 25, 2025 |
| PRE 14A | PRE 14A | 0001193125-25-082777 | Apr 16, 2025 | Jun 25, 2025 |
| EFFECT | — | 9999999995-25-000975 | Apr 3, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-072387 | Apr 3, 2025 | — |
| CORRESP | — | 0001193125-25-070406 | Apr 1, 2025 | — |
| UPLOAD | — | 0000000000-25-003496 | Apr 1, 2025 | — |
| S-3 | S-3 | 0001193125-25-065499 | Mar 27, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-038262 | Mar 12, 2025 | — |
| S-8 | S-8 | 0001193125-25-050851 | Mar 10, 2025 | — |
| 10-K | 10-K | 0000950170-25-035929 | Mar 10, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001171843-25-001352 | Mar 10, 2025 | — |
| 4 | — | 0001610717-25-000046 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001610717-25-000045 | Mar 4, 2025 | Feb 28, 2025 |